@article{24f3ca073d76477d9ec65ef5da9f9071,
title = "Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection",
abstract = "Progenitor-like CD8+ T cells mediate long-term immunity to chronic infection and cancer and respond potently to immune checkpoint blockade. These cells share transcriptional regulators with memory precursor cells, including T cell-specific transcription factor 1 (TCF1), but it is unclear whether they adopt distinct programs to adapt to the immunosuppressive environment. By comparing the single-cell transcriptomes and epigenetic profiles of CD8+ T cells responding to acute and chronic viral infections, we found that progenitor-like CD8+ T cells became distinct from memory precursor cells before the peak of the T cell response. We discovered a coexpression gene module containing Tox that exhibited higher transcriptional activity associated with more abundant active histone marks in progenitor-like cells than memory precursor cells. Moreover, thymocyte selection-associated high mobility group box protein TOX (TOX) promoted the persistence of antiviral CD8+ T cells and was required for the programming of progenitor-like CD8+ T cells. Thus, long-term CD8+ T cell immunity to chronic viral infection requires unique transcriptional and epigenetic programs associated with the transcription factor TOX.",
author = "Chen Yao and Sun, {Hong Wei} and Lacey, {Neal E.} and Yun Ji and Moseman, {E. Ashley} and Shih, {Han Yu} and Heuston, {Elisabeth F.} and Martha Kirby and Stacie Anderson and Jun Cheng and Omar Khan and Robin Handon and Julie Reilley and Jessica Fioravanti and Jinhui Hu and Selamawit Gossa and Wherry, {E. John} and Luca Gattinoni and McGavern, {Dorian B.} and O{\textquoteright}Shea, {John J.} and Schwartzberg, {Pamela L.} and Tuoqi Wu",
note = "Funding Information: We thank L. Garrett (NHGRI), E. Escobar (NHGRI), C. Rivas (NHGRI), I. Ginty (NHGRI), W. Pridgen (NHGRI), G. Gutierrez-Cruz (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)) and S. Dell{\textquoteright}Orso (NIAMS) for their excellent technical support and J. Kaye for the ToxloxP/loxP mice. This work was supported in part by the intramural programs of the NHGRI, National Institute of Allergy and Infectious Diseases, NIAMS and National Institute of Neurological Disorders and Stroke, and the National Cancer Institute, National Institutes of Health (NIH) and DDIR Innovation Awards to P.L.S., J.J.O. and L.G., and NIH grant (no. AG056524 to T.W). E.J.W. is a member of the Parker Institute for Cancer Immunotherapy, which supported the University of Pennsylvania cancer immunotherapy program. Publisher Copyright: {\textcopyright} 2019, The Author(s), under exclusive licence to Springer Nature America, Inc.",
year = "2019",
month = jul,
day = "1",
doi = "10.1038/s41590-019-0403-4",
language = "English (US)",
volume = "20",
pages = "890--901",
journal = "Nature immunology",
issn = "1529-2908",
publisher = "Nature Publishing Group",
number = "7",
}